Cutler Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-300
| Closed | -$7K | – | 1338 |
|
|
2023
Q3 | $7K | Buy |
+300
| New | +$7K | ﹤0.01% | 1085 |
|
|
2023
Q2 | – | Sell |
-1,746
| Closed | -$28K | – | 1399 |
|
|
2023
Q1 | $28K | Buy |
1,746
+446
| +34% | +$7.15K | ﹤0.01% | 774 |
|
|
2022
Q4 | $9K | Sell |
1,300
-200
| -13% | -$1.39K | ﹤0.01% | 1300 |
|
|
2022
Q3 | $14K | Sell |
1,500
-400
| -21% | -$3.73K | ﹤0.01% | 1280 |
|
|
2022
Q2 | $17K | Sell |
1,900
-12,592
| -87% | -$113K | ﹤0.01% | 1225 |
|
|
2022
Q1 | $147K | Sell |
14,492
-15,112
| -51% | -$153K | 0.01% | 685 |
|
|
2021
Q4 | $493K | Buy |
+29,604
| New | +$493K | 0.02% | 404 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2130 |
|
|
2021
Q2 | – | Sell |
-1,200
| Closed | -$73K | – | 2139 |
|
|
2021
Q1 | $73K | Buy |
1,200
+426
| +55% | +$25.9K | ﹤0.01% | 1010 |
|
|
2020
Q4 | $55K | Buy |
+774
| New | +$55K | ﹤0.01% | 975 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1712 |
|
|
2020
Q2 | – | Sell |
-3,800
| Closed | -$110K | – | 1569 |
|
|
2020
Q1 | $110K | Buy |
+3,800
| New | +$110K | 0.01% | 577 |
|